RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Integrated Meta-Analysis Identifies Keratin Family Genes and Associated Genes as Key Biomarkers and Therapeutic Targets in Metastatic Cutaneous Melanoma.
Integrated Meta-Analysis Identifies Keratin Family Genes and Associated Genes as Key Biomarkers and Therapeutic Targets in Metastatic Cutaneous Melanoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
在本研究中,我们检索了四个与原发性及转移性黑色素瘤组织相关的数据集(GSE15605、GSE46517、GSE8401和GSE7553),并鉴定了差异表达基因(DEGs)。此后,对DEGs进行了整合荟萃分析和功能富集分析,以评估参与黑色素瘤转移的分子机制,如免疫细胞解卷积和蛋白质-蛋白质相互作用(PPI)网络构建。基于四种拓扑学方法,包括“Betweenness”、“MCC”、“Degree”和“Bottleneck”,鉴定了枢纽基因。我们使用TCGA-SKCM队列验证了这些发现。使用DGIdb评估药物-基因相互作用,而使用ProteinPlus和AlphaFold数据库评估结构可成药性。
我们共鉴定了十一个与黑色素瘤进展相关的枢纽基因。这些包括角蛋白基因家族成员(例如KRT5、KRT6A、KRT6B等)。除基因CDH1外,所有枢纽基因在转移性黑色素瘤组织中均下调。从预后角度来看,这些枢纽基因与不良预后(即不利)相关。使用人类蛋白质图谱(HPA),免疫组织化学评估显示转移性黑色素瘤中大多未检测到表达水平。此外,角化包膜形成是最富集的通路,基因比率为17/33。转移性黑色素瘤的肿瘤微环境(TME)主要富集NK细胞相关特征。最后,若干枢纽基因显示出良好的免疫治疗可成药潜力。
通过整合荟萃分析,本研究识别了黑色素瘤转移的转录、免疫和结构通路,并强调角蛋白家族基因作为治疗靶向的有前景的生物标志物。
Background/Objectives: Cutaneous melanoma is one of the aggressive forms of skin cancer originating from melanocytes. The high incidence of melanoma metastasis continues to rise, partly due to the complex nature of the molecular mechanisms driving its progression. While melanomas generally arise from melanocytes, we investigated whether aberrant keratinocyte differentiation pathways-like cornified envelope formation-discriminate primary melanoma from metastatic melanoma, revealing novel biomarkers in progression.
Methods: In the present study, we retrieved four datasets (GSE15605, GSE46517, GSE8401, and GSE7553) associated with primary and metastatic melanoma tissues and identified differentially expressed genes (DEGs).
Thereafter, an integrated meta-analysis and functional enrichment analysis of the DEGs were performed to evaluate the molecular mechanisms involved in melanoma metastasis, such as immune cell deconvolution and protein-protein interaction (PPI) network construction. Hub genes were identified based on four topological methods, including 'Betweenness', 'MCC', 'Degree', and 'Bottleneck'.
We validated the findings using the TCGA-SKCM cohort. Drug-gene interactions were evaluated using the DGIdb, whereas structural druggability was assessed using the ProteinPlus and AlphaFold databases. Results: We identified a total of eleven hub genes associated with melanoma progression. These included members of the keratin gene family (e. g.
, KRT5, KRT6A, KRT6B, etc.) . Except for the gene CDH1, all the hub genes were downregulated in metastatic melanoma tissues. From a prognostic perspective, these hub genes were associated with poor prognosis (i. e. , unfavorable). Using the Human Protein Atlas (HPA), immunohistochemistry evaluation revealed mostly undetected levels in metastatic melanoma.
Additionally, the cornified envelope formation was the most enriched pathway, with a gene ratio of 17/33. The tumor microenvironment (TME) of metastatic melanomas was predominantly enriched in NK cell-associated signatures.
Finally, several hub genes demonstrated favorable druggable potential for immunotherapy. Conclusions: Through integrated meta-analysis, this study identifies transcriptional, immunological, and structural pathways to melanoma metastasis and highlights keratin family genes as promising biomarkers for therapeutic targeting.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。